Search research articles
Contact Us
Filters
Showing results (181-190 of 185) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 185 results.
Angewandte Chemie (International Ed. in English)
|
February 10, 2026
The Important Role of Carbonyl in Accelerating Reverse Intersystem Crossing for Selenium-Based Organoboron Narrowband Blue Emitters
Zhihai Yang, Yuling Chen, Zijian Chen, et al.
The Plant Journal : for Cell and Molecular Biology
|
January 27, 2025
A Ralstonia effector RipAU impairs peanut AhSBT1.7 immunity for pathogenicity via AhPME-mediated cell wall degradation
Kun Chen, Yuhui Zhuang, Hua Chen, et al.
Renal Failure
|
July 24, 2023
Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
Xiaoyan Ma, Lu Fang, Lili Sheng, et al.
Nature Communications
|
June 12, 2023
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer
Shen Zhao, Wu Zhuang, Baohui Han, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 6, 2026
DCAF13 Safeguards Hematopoietic Stem Cells via RRS1-Regulated Ribosome Biogenesis
Mengke Li, Yuxin Wu, Shuai Zhou, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 185) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 185 results.
Angewandte Chemie (International Ed. in English)
|
February 10, 2026
The Important Role of Carbonyl in Accelerating Reverse Intersystem Crossing for Selenium-Based Organoboron Narrowband Blue Emitters
Zhihai Yang, Yuling Chen, Zijian Chen, et al.
The Plant Journal : for Cell and Molecular Biology
|
January 27, 2025
A Ralstonia effector RipAU impairs peanut AhSBT1.7 immunity for pathogenicity via AhPME-mediated cell wall degradation
Kun Chen, Yuhui Zhuang, Hua Chen, et al.
Renal Failure
|
July 24, 2023
Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
Xiaoyan Ma, Lu Fang, Lili Sheng, et al.
Nature Communications
|
June 12, 2023
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer
Shen Zhao, Wu Zhuang, Baohui Han, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 6, 2026
DCAF13 Safeguards Hematopoietic Stem Cells via RRS1-Regulated Ribosome Biogenesis
Mengke Li, Yuxin Wu, Shuai Zhou, et al.
Page
of 19